查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2016749

糖尿病視網膜病變市場規模、佔有率、趨勢和預測：按類型、治療類型、最終用戶和地區分類，2026-2034 年

Diabetic Retinopathy Market Size, Share, Trends and Forecast by Type, Treatment Type, End-User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

2025年全球糖尿病視網膜病變市場規模為89億美元。展望未來，IMARC Group預測，該市場將在2026年至2034年間以4.63%的複合年成長率成長，到2034年達到136億美元。北美目前在該市場佔據主導地位，預計2025年將佔據超過43.8%的市場。這主要歸功於該地區糖尿病的高發病率、先進的醫療基礎設施以及對創新診斷方法和抗VEGF療法的早期應用。此外，有利的健保政策和對研發的大力投入也進一步鞏固了該地區在糖尿病視網膜病變市場的領先地位。

糖尿病視網膜病變（DR）是糖尿病的常見併發症，會影響視網膜－眼睛中感知光線並將訊號傳遞至大腦的部分。當高血糖損害視網膜中的微血管時，就會發生DR，導致這些血管滲漏或阻塞。如果不及時治療，會導致視力喪失甚至失明。糖尿病視網膜病變主要分為兩種：非增殖性糖尿病視網膜病變及增殖性糖尿病視網膜病變。診斷需要進行全面的眼科檢查，包括螢光造影和光學同調斷層掃描（OCT）等檢查。這些檢查有助於確定DR的存在和嚴重程度，從而實現早期干預和治療。目前，DR有多種治療方法，包括眼內注射類固醇、雷射治療和玻璃體切除手術。眼內注射類固醇有助於減輕眼部發炎和腫脹，而雷射治療則用於阻塞滲漏的血管，防止對視網膜造成進一步損害。在更嚴重的情況下，可能需要玻璃體切除手術，以清除眼內的血液和疤痕組織。

糖尿病視網膜病變市場的發展趨勢：

全球糖尿病視網膜病變市場正經歷顯著成長，主要促進因素是糖尿病盛行率的上升和老年人口的增加。因此，主要企業正積極研發糖尿病視網膜病變的新治療方法，進一步推動市場成長。此外，抗血管內皮生長因子（VEGF）藥物和緩釋植入等新藥和療法的研發也顯著促進了市場成長。遠距遠端醫療和人工智慧（AI）在糖尿病視網膜病變診斷和治療中的日益普及也推動了市場成長。人們對糖尿病視網膜病變及其潛在併發症的認知不斷提高，增加了對有效治療方法的需求，這也是推動市場成長的因素之一。此外，人們對糖尿病視網膜病變早期診斷和治療的認知不斷提高，以及眼科技術的進步，也為市場成長提供了支持。其他促進市場成長的因素包括醫療保健支出增加、政府為改善眼科醫療服務而推出的各項措施以及優惠的報銷政策。

本報告解答的主要問題：

  • 全球糖尿病視網膜病變市場迄今的發展軌跡如何？預計未來幾年將如何發展？
  • 全球糖尿病視網膜病變市場的市場促進因素、限制因素和機會是什麼？
  • 各種促進因素​​、阻礙因素和機會如何影響全球糖尿病視網膜病變市場？
  • 主要區域市場有哪些？
  • 哪個國家擁有最具吸引力的糖尿病視網膜病變市場？
  • 按類型分類的市場組成是什麼？
  • 市面上哪種類型的糖尿病視網膜病變模型最受歡迎？
  • 按治療類型分類的市場組成是什麼？
  • 在糖尿病視網膜病變市場中，哪種治療方法最具吸引力？
  • 依最終用戶分類的市場區隔如何？
  • 在糖尿病視網膜病變市場中，最具吸引力的終端使用者群體是什麼？
  • 全球糖尿病視網膜病變市場的競爭格局如何？
  • 全球糖尿病視網膜病變市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球糖尿病視網膜病變市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 增殖性糖尿病視網膜病變
  • 非增殖性視網膜病變

第7章 市場區隔：依治療類型分類

  • 抗 VEGF 藥物
  • 類固醇植入
  • 雷射手術
  • 玻璃體切除手術

第8章 市場區隔：依最終用戶分類

  • 醫院和藥房
  • 眼科診所
  • 門診手術中心（ASC）
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Alimera Sciences
    • Allergan Plc
    • Ampio Pharmaceuticals
    • Bayer Healthcare
    • BCN Peptides
    • Genentech
    • Kowa Group
    • Novartis AG
    • Regeneron Pharmaceuticals Inc.
    • Sirnaomics Inc.
Product Code: SR112026A1932

The global diabetic retinopathy market size was valued at USD 8.9 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 13.6 Billion by 2034, exhibiting a CAGR of 4.63% during 2026-2034. North America currently dominates the market, holding a significant market share of over 43.8% in 2025, owing to its high diabetes prevalence, advanced healthcare infrastructure, and early adoption of innovative diagnostics and anti-VEGF therapies. Supportive reimbursement policies and strong R&D investment further strengthen the region's dominance in the diabetic retinopathy market share.

Diabetic retinopathy (DR) is a common complication of diabetes that affects the retina, the part of the eye that senses light and sends signals to the brain. It occurs when high blood sugar levels damage the small blood vessels in the retina, causing them to leak or become blocked. This can lead to vision loss or blindness if left untreated. There are two main types of diabetic retinopathy, namely non-proliferative diabetic retinopathy and proliferative diabetic retinopathy. Its diagnosis involves a comprehensive eye exam, which may include tests such as fluorescein angiography and optical coherence tomography. These tests can help to identify the presence and severity of DR, allowing for early intervention and treatment. Currently, there are several treatment options available for DR, including the use of intraocular steroid injections, laser treatment, and vitrectomy. Intraocular steroid injections can help to reduce inflammation and swelling in the eye, while laser treatment can be used to seal leaking blood vessels and prevent further damage to the retina. In more severe cases, a vitrectomy may be necessary to remove blood or scar tissue from the eye.

Diabetic Retinopathy Market Trends:

The global diabetic retinopathy market is witnessing significant growth, primarily driven by the rising prevalence of diabetes and the increasing geriatric population. In line with this, key players are actively working to develop new therapeutic solutions for diabetic retinopathy, which is bolstering market growth. Apart from this, the development of new drugs and therapies, such as anti-VEGF agents and sustained-release implants, has also significantly contributed to market growth. Additionally, the escalating adoption of telemedicine and artificial intelligence (AI) in the diagnosis and treatment of diabetic retinopathy is driving the market growth. The rising demand for effective treatments due to the growing awareness of diabetic retinopathy and its potential consequences is acting as another growth-inducing factor. Furthermore, the surging awareness regarding early diagnosis and treatment of diabetic retinopathy, coupled with advancements in ophthalmic technology, are fueling the market growth. Other factors, such as increasing healthcare expenditure, the implementation of various government initiatives to improve eye care services, and the availability of favorable reimbursement policies, are propelling the market growth.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global diabetic retinopathy market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on type, treatment type and end-user.

Type Insights:

  • Proliferative Diabetic Retinopathy
  • Non-proliferative Retinopathy

Treatment Type Insights:

  • Anti VEGF Drugs
  • Steroid Implants
  • Laser Surgeries
  • Vitrectomy

End-User Insights:

  • Hospitals and Pharmacies
  • Eye Clinics
  • Ambulatory Surgical Centres (ASCs)
  • Others

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. As per the report, North America dominates the market. Some of the factors accelerating the North America diabetic retinopathy market include the increasing prevalence of diabetes, growing awareness about diabetic retinopathy, and advancements in diagnostic and treatment technologies.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global diabetic retinopathy market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Alimera Sciences, Allergan PLC, Ampio Pharmaceuticals, Bayer Healthcare, BCN Peptides, Genentech, Kowa Group, Novartis AG, Regeneron Pharmaceuticals Inc., Sirnaomics Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global diabetic retinopathy market performed so far, and how will it perform in the coming years ?
  • What are the drivers, restraints, and opportunities in the global diabetic retinopathy market ?
  • What is the impact of each driver, restraint, and opportunity on the global diabetic retinopathy market ?
  • What are the key regional markets ?
  • Which countries represent the most attractive diabetic retinopathy market ?
  • What is the breakup of the market based on the type ?
  • Which is the most attractive type in the diabetic retinopathy market ?
  • What is the breakup of the market based on the treatment type ?
  • Which is the most attractive treatment type in the diabetic retinopathy market ?
  • What is the breakup of the market based on the end-user ?
  • Which is the most attractive end-user in the diabetic retinopathy market ?
  • What is the competitive structure of the global diabetic retinopathy market ?
  • Who are the key players/companies in the global diabetic retinopathy market ?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Diabetic Retinopathy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Proliferative Diabetic Retinopathy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-proliferative Retinopathy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Anti VEGF Drugs
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Steroid Implants
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Laser Surgeries
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Vitrectomy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospitals and Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Eye Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Surgical Centres (ASCs)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Alimera Sciences
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
    • 13.3.2 Allergan Plc
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Ampio Pharmaceuticals
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Bayer Healthcare
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 BCN Peptides
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Genentech
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 SWOT Analysis
    • 13.3.7 Kowa Group
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Novartis AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Regeneron Pharmaceuticals Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Sirnaomics Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Diabetic Retinopathy Market: Sales Value (in Billion USD), 2020-2025
  • Figure 2: Global: Diabetic Retinopathy Market: Breakup by Type (in %), 2025
  • Figure 3: Global: Diabetic Retinopathy Market: Breakup by Treatment Type (in %), 2025
  • Figure 4: Global: Diabetic Retinopathy Market: Breakup by End-User (in %), 2025
  • Figure 5: Global: Diabetic Retinopathy Market: Breakup by Region (in %), 2025
  • Figure 6: Global: Diabetic Retinopathy Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 7: Global: Diabetic Retinopathy (Proliferative Diabetic Retinopathy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Diabetic Retinopathy (Proliferative Diabetic Retinopathy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Diabetic Retinopathy (Non-proliferative Retinopathy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Diabetic Retinopathy (Non-proliferative Retinopathy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Diabetic Retinopathy (Anti VEGF Drugs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Diabetic Retinopathy (Anti VEGF Drugs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Diabetic Retinopathy (Steroid Implants) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Diabetic Retinopathy (Steroid Implants) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Diabetic Retinopathy (Laser Surgeries) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Diabetic Retinopathy (Laser Surgeries) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Diabetic Retinopathy (Vitrectomy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Diabetic Retinopathy (Vitrectomy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Diabetic Retinopathy (Hospitals and Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Diabetic Retinopathy (Hospitals and Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Diabetic Retinopathy (Eye Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Diabetic Retinopathy (Eye Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Diabetic Retinopathy (Ambulatory Surgical Centres-ASCs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Diabetic Retinopathy (Ambulatory Surgical Centres-ASCs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Diabetic Retinopathy (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Diabetic Retinopathy (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: North America: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: North America: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: United States: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: United States: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Canada: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Canada: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Asia Pacific: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Asia Pacific: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: China: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: China: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Japan: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Japan: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: India: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: India: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: South Korea: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: South Korea: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Australia: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Australia: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Indonesia: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Indonesia: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Others: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Europe: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Europe: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Germany: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Germany: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: France: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: France: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: United Kingdom: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: United Kingdom: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Italy: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Italy: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Spain: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Spain: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Russia: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Russia: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Others: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Latin America: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Latin America: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Brazil: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Brazil: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Mexico: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Mexico: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Others: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Middle East and Africa: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Middle East and Africa: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Global: Diabetic Retinopathy Industry: SWOT Analysis
  • Figure 76: Global: Diabetic Retinopathy Industry: Value Chain Analysis
  • Figure 77: Global: Diabetic Retinopathy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Diabetic Retinopathy Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Diabetic Retinopathy Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Diabetic Retinopathy Market Forecast: Breakup by Treatment Type (in Million USD), 2026-2034
  • Table 4: Global: Diabetic Retinopathy Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 5: Global: Diabetic Retinopathy Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Diabetic Retinopathy Market: Competitive Structure
  • Table 7: Global: Diabetic Retinopathy Market: Key Players